deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks
Open accessAbstract
With the advances in high-throughput technologies, millions of somatic mutations have been reported in the past decade. Identifying driver genes with oncogenic mutations from these data is a critical and challenging problem. Many computational methods have been proposed to predict driver genes. Among them, machine learning-based methods usually train a classifier with representations that concatenate various types of features extracted from different kinds of data. Although successful, simply concatenating different types of features may not be the best way to fuse these data. We notice that a few types of data characterize the similarities of genes, to better integrate them with other data and improve the accuracy of driver gene prediction, in this study, a deep learning-based method (deepDriver) is proposed by performing convolution on mutation-based features of genes and their neighbors in the similarity networks. The method allows the convolutional neural network to learn information within mutation data and similarity networks simultaneously, which enhances the prediction of driver genes. deepDriver achieves AUC scores of 0.984 and 0.976 on breast cancer and colorectal cancer, which are superior to the competing algorithms. Further evaluations of the top 10 predictions also demonstrate that deepDriver is valuable for predicting new driver genes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AI is used in nearly every step of next-generation sequencing processing and interpretation, including mutation identification, artifact filtering, and driver gene identification.
“This includes the use of AI in nearly every step of next-generation sequencing (NGS) processing and interpretation, including mutation identification (122, 123), artifact filtering (124), and driver gene identification (125).”
From Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions (2024) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Nearest neighbor pattern classification
Cover, T., & Hart, P. (1967) · IEEE Transactions on Information Theory · doi:10.1109/tit.1967.1053964 · Cited by 16,936 · cited 1× · see citing works
“An undirected network N is constructed by k -nearest neighbors (kNN) algorithm (Cover and Hart, 1967) in which every gene is connected to genes that have the k largest PCC scores with itself.”
MethodVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 2× · see citing works
“These 12 features have been used in many machining learning-based methods (Vogelstein et al., 2013; Tokheim et al., 2016).”
MethodKumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521 · cited 1× · see citing works
“CanDrA trains an SVM with 95 features obtained from 10 functional impact-based algorithms, such as SIFT (Kumar et al., 2009) and CHASM.”
MethodHuman Protein Reference Database--2009 update
Prasad, T. S. K., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, R. B., Venugopal, A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn892 · Cited by 3,241 · cited 1× · see citing works
“Considering that GINs are downloaded from online databases, such as BioGrid (Chatr-Aryamontri et al., 2017) and HPRD (Keshava Prasad et al., 2008), which contain many false positives, network-based methods need more accurate GIN to improve their prediction accuracy.”
MethodDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 3× · see citing works
“Tokheim et al. propose a random forest algorithm (known as 20/20+) and compare it with seven classical driver gene prediction algorithms [ActiveDriver (Reimand and Bader, 2013), MuSiC (Dees et al., 2012), MutsigCV (Lawrence et al., 2014), OncodriveCLUST (Tamborero et al., 2013), OncodriveFM (Gonzalez-Perez and Lopez-B…”
MethodResultA systematic study of the class imbalance problem in convolutional neural networks
Buda, M., Maki, A., & Mazurowski, M. A. (2018) · Neural Networks · doi:10.1016/j.neunet.2018.07.011 · Cited by 3,088 · cited 1× · see citing works
“Currently, two types of methods can be used to solve the imbalanced problem: data level methods and classifier level methods (Buda et al., 2018).”
MethodComprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,316 · see citing works
COSMIC: somatic cancer genetics at high-resolution
Forbes, S. A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C. G., Ward, S., Dawson, E., Ponting, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1121 · Cited by 1,922 · cited 5× · see citing works
“In addition to the driver genes collected from CGC, our deepDriver was also validated using the driver genes published in Bailey et al. (2018).”
MethodInfluentialToward a Shared Vision for Cancer Genomic Data
Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680 · cited 1× · see citing works
“The mutation data and gene expression data of these three diseases were downloaded from the NCI Genomic Data Commons (GDC) (Grossman et al., 2016).”
MethodThe BioGRID interaction database: 2017 update
Chatr‐aryamontri, A., Oughtred, R., Boucher, L., Rust, J., Chang, C., Kolas, N. K., O’Donnell, L., Oster, S. K., Theesfeld, C. L., Sellam, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1102 · Cited by 960 · see citing works
Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815 · see citing works
MuSiC: Identifying mutational significance in cancer genomesPreprint
Dees, N. D., Zhang, Q., Kandoth, C., Wendl, M. C., Schierding, W. S., Koboldt, D. C., Mooney, T. B., Callaway, M. B., Dooling, D. J., Mardis, E. R., et al. (2012) · Genome Research · doi:10.1101/gr.134635.111 · Cited by 669 · cited 3× · see citing works
“Tokheim et al. propose a random forest algorithm (known as 20/20+) and compare it with seven classical driver gene prediction algorithms [ActiveDriver (Reimand and Bader, 2013), MuSiC (Dees et al., 2012), MutsigCV (Lawrence et al., 2014), OncodriveCLUST (Tamborero et al., 2013), OncodriveFM (Gonzalez-Perez and Lopez-B…”
MethodResultIntOGen-mutations identifies cancer drivers across tumor types
González-Pérez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M. P., Jené-Sanz, A., Santos, A., & López-Bigas, N. (2013) · Nature Methods · doi:10.1038/nmeth.2642 · Cited by 570 · cited 3× · see citing works
“KMT2C Gala et al., 2018 PTEN Kechagioglou et al., 2014 ANKRD12 NF1 Uusitalo et al., 2017 ANKHD1-EIF4EBP3 ARID4B MCM7 MYO6 MLLT4 Gonzalez-Perez et al., 2013 CEP128”
BackgroundHijacked in cancer: the MLL/KMT2 family of methyltransferases
Rao, R., & Dou, Y. (2015) · Nature Reviews. Cancer · doi:10.1038/nrc3929 · Cited by 558 · cited 1× · see citing works
““KMT2A” belongs to the KMT2 family which is related to COAD (Rao and Dou, 2015).”
BackgroundOncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes
Tamborero, D., González-Pérez, A., & López-Bigas, N. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt395 · Cited by 483 · cited 4× · see citing works
“Tokheim et al. propose a random forest algorithm (known as 20/20+) and compare it with seven classical driver gene prediction algorithms [ActiveDriver (Reimand and Bader, 2013), MuSiC (Dees et al., 2012), MutsigCV (Lawrence et al., 2014), OncodriveCLUST (Tamborero et al., 2013), OncodriveFM (Gonzalez-Perez and Lopez-B…”
BackgroundMethodInfluentialEvaluating the evaluation of cancer driver genes
Tokheim, C., Papadopoulos, N., Kinzler, K., Vogelstein, B., & Karchin, R. (2016) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1616440113 · Cited by 365 · cited 3× · see citing works
“These 12 features have been used in many machining learning-based methods (Vogelstein et al., 2013; Tokheim et al., 2016).”
BackgroundMethodFunctional impact bias reveals cancer drivers
González-Pérez, A., & López-Bigas, N. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks743 · Cited by 328 · cited 2× · see citing works
“, 2013), OncodriveFM (Gonzalez-Perez and Lopez-Bigas, 2012), OncodriveFML (Mularoni et al.”
Genenames.org: the HGNC and VGNC resources in 2017
Yates, B., Braschi, B., Gray, K. A., Seal, R. L., Tweedie, S., & Bruford, E. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1033 · Cited by 328 · cited 1× · see citing works
“Gene ids were standardized to the gene names provided by HUGO Gene Nomenclature Committee (downloaded Aug 1, 2018) (Yates et al., 2016).”
MethodMularoni, L., Sabarinathan, R., Deu-Pons, J., González-Pérez, A., & López-Bigas, N. (2016) · Genome biology · doi:10.1186/s13059-016-0994-0 · Cited by 322 · cited 2× · see citing works
“…[ActiveDriver (Reimand and Bader, 2013), MuSiC (Dees et al., 2012), MutsigCV (Lawrence et al., 2014), OncodriveCLUST (Tamborero et al., 2013), OncodriveFM (Gonzalez-Perez and Lopez-Bigas, 2012), OncodriveFML (Mularoni et al., 2016) and TUSON ( Davoli et al., 2013)] in Tokheim et al. (2016).”
BackgroundRubio-Perez, C., Tamborero, D., Schroeder, M. P., Antolín, A. A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., Gonzalez-Perez, A., & Lopez-Bigas, N. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.007 · Cited by 296 · see citing works
Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers
Reimand, J., & Bader, G. D. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.68 · Cited by 270 · see citing works
DawnRank: discovering personalized driver genes in cancer
Hou, J. P., & Ma, J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0056-8 · Cited by 268 · cited 1× · see citing works
“For example, DawnRank predicts driver genes by ranking the genes in a gene interaction network (GIN) with PageRank algorithm (Hou and Ma, 2014).”
MethodLee, S., Stewart, S. A., Nagtegaal, I. D., Luo, J. R., Wu, Y., Colditz, G. A., Medina, D., & Allred, D. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0636 · Cited by 158 · see citing works
Models for transcript quantification from RNA-SeqPreprint
Pachter, L. S. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1104.3889 · Cited by 155 · cited 1× · see citing works
“We chose the data normalized by FPKM and converted the values to TPM by the method proposed in Pachter (2011).”
MethodLi, S., Mei, Z., Hu, H., & Zhang, X. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26325 · Cited by 152 · see citing works
Cheng, F., Zhao, J., & Zhao, Z. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv068 · Cited by 148 · see citing works
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
Gala, K. P., Li, Q., Sinha, A., Razavi, P., Dorso, M. A., Sánchez-Vega, F., Chung, Y. R., Hendrickson, R. C., Hsieh, J. J.-D., Berger, M. F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0273-5 · Cited by 133 · see citing works
CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer
Wong, W. C., Kim, D., Carter, H. K., Diekhans, M., Ryan, M., & Karchin, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr357 · Cited by 125 · cited 1× · see citing works
“For instance, CHASM trains a random forest classifier with 86 predictive features (Wong et al., 2011).”
MethodGuo, W.-F., Zhang, S., Liu, L., Liu, F., Shi, Q., Zhang, L., Tang, Y. Z., Zeng, T., & Chen, L. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty006 · Cited by 114 · cited 1× · see citing works
“SCS uses network control strategy to find driver mutations that can drive the regulation network from the normal state to disease states (Guo et al., 2018).”
BackgroundInherited DNA-Repair Defects in Colorectal Cancer
AlDubayan, S. H., Giannakis, M., Moore, N. D., Han, G. C., Reardon, B. M., Hamada, T., Mu, X. J., Nishihara, R., Qian, Z., Liu, L., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.018 · Cited by 114 · see citing works
The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer
Honda, K. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0031-0 · Cited by 112 · see citing works
Wang, H., Shen, Q., Zhang, X., Yang, C.-L., Cui, S., Sun, Y., Wang, L., Fan, X., & Xu, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475637 · Cited by 107 · see citing works
Targeting mTOR network in colorectal cancer therapy
Wang, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i15.4178 · Cited by 100 · see citing works
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
Kechagioglou, P., Papi, R. M., Provatopoulou, X., Kalogera, E., Papadimitriou, E., Grigoropoulos, P., Nonni, A., Zografos, G., Kyriakidis, D. A., & Gounaris, A. (2014) · PubMed · Cited by 95 · see citing works
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors
Uusitalo, E., Kallionpää, R. A., Kurki, S. H., Rantanen, M. E., Pitkäniemi, J. M., Kronqvist, P., Härkönen, P. L., Huovinen, R., Carpén, O., Pöyhönen, M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.403 · Cited by 92 · see citing works
Different prognostic impact ofSTK11mutations in non-squamous non-small-cell lung cancer
Pécuchet, N., Laurent‐Puig, P., Mansuet‐Lupo, A., Legras, A., Alifano, M., Pallier, K., Didelot, A., Gibault, L., Danel, C. J., Just, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6379 · Cited by 87 · see citing works
Clinical and Molecular Characteristics of NF1 -Mutant Lung Cancer
Redig, A. J., Capelletti, M., Dahlberg, S. E., Sholl, L. M., Mach, S. L., Fontes, C., Shi, Y., Chalasani, P., & Janne, P. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2377 · Cited by 84 · see citing works
Cao, J., Ge, M., & Ling, Z. (2016) · Medicine · doi:10.1097/md.0000000000002496 · Cited by 83 · cited 2× · see citing works
“PTEN Kechagioglou et al., 2014 HCFC1 Gonzalez-Perez et al., 2013; Rubio-Perez et al., 2015 UTRN Cornen et al., 2014 ZNF517 STAG2 Gonzalez-Perez et al., 2013; Rubio-Perez et al., 2015 ZFP36L1 Loh et al., 2017 ZNF91 VPS13C DST FBXW7 Cao et al., 2016”
Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Kikuchi, S., Yamada, D., Fukami, T., Masuda, M., Sakurai‐Yageta, M., Williams, Y. N., Maruyama, T., Asamura, H., Matsuno, Y., Onizuka, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2206 · Cited by 79 · cited 1× · see citing works
“LRRIQ1 HECTD4 EPB41L3 Kikuchi et al., 2005 NF1 Redig et al., 2016 CEP350 PRKDC APC MYH9 POSTN FN1 number of genes that have been studied as drivers in existing literature.”
BackgroundThe inhibitory effects of COL1A2 on colorectal cancer cell proliferation, migration, and invasion
Yu, Y., Liu, D., Liu, Z., Li, S., Ge, Y., Sun, W., & Liu, B. (2018) · Journal of Cancer · doi:10.7150/jca.25542 · Cited by 70 · see citing works
Cornen, S., Guillé, A., Adélaı̈de, J., Addou-Klouche, L., Finetti, P., Saade, M.-R., Manai, M., Carbuccia, N., Bekhouche, I., Letessier, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0081843 · Cited by 69 · see citing works
Disease Gene Prediction by Integrating PPI Networks, Clinical RNA-Seq Data and OMIM Data
Luo, P., Tian, L., Ruan, J., & Wu, F. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2770120 · Cited by 69 · cited 1× · see citing works
“Based on our previous study, k = 7 is enough to generate high-quality similarity networks (Luo et al., 2017).”
BackgroundExome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
Pamplona, R. S., López‐Doriga, A., Paré, L., Lázaro, K., Bellido, F., Alonso, M. H., Aussó, S., Guinó, E., Beltrán, S., Castro-Giner, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0159 · Cited by 62 · see citing works
Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors
Haeger, S. M., Thompson, J. J., Kalra, S., Cleaver, T. G., Merrick, D. T., Wang, X., & Malkoski, S. P. (2015) · Oncogene · doi:10.1038/onc.2015.112 · Cited by 47 · see citing works
Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer
Yu, J. Q., Wu, W. K. K., Liang, Q., Zhang, N., He, J., Li, X., Zhang, X., Xu, L., Chan, M. T. V., Ng, S. S. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.72 · Cited by 47 · see citing works
The dose-dependent effect of SOX9 and its incidence in colorectal cancer
Prévostel, C., & Blache, P. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.037 · Cited by 47 · see citing works
IEEE/ACM Transactions on Computational Biology and Bioinformatics
Bergeron, A., Chauve, C., & Paul, C. (2008) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2008.927644 · Cited by 43 · see citing works
He, P., Li, K., Li, S.-B., Hu, T., Guan, M., Sun, F., & Liu, W.-W. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4284 · Cited by 35 · see citing works
Choi, M. R., An, C. H., Yoo, N. J., & Lee, S. H. (2014) · Apmis · doi:10.1111/apm.12309 · Cited by 34 · cited 1× · see citing works
““LAMA3” were predicted as biomarkers which could be used to diagnose COAD in the early stage (Choi et al., 2015).”
BackgroundKoo, B.-S., Hurskainen, T. L., Mielke, K., Aung, P. P., Casey, G., Autio‐Harmainen, H., & Apte, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22882 · Cited by 25 · cited 1× · see citing works
“Meanwhile, among the rest 5 genes, “AMER1” and “ADAMTSL3” were found to be frequently mutated in COAD (Koo et al., 2007; Sanz-Pamplona et al., 2015).”
BackgroundFriedrich, T., Söhn, M., Gutting, T., Janssen, K., Behrens, H., Röcken, C., Ebert, M. P. A., & Burgermeister, E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.003 · Cited by 21 · see citing works
The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies
Meriggi, F. A., Vermi, W., Bertocchi, P., & Zaniboni, A. (2014) · Reviews on Recent Clinical Trials · doi:10.2174/1568026614666140423121525 · Cited by 20 · see citing works
Velmurugan, K. R., Varghese, R. T., Fonville, N. C., & Garner, H. R. (2017) · Oncogene · doi:10.1038/onc.2017.256 · Cited by 11 · cited 1× · see citing works
“The tenth gene “HERC2P3” contains a microsatellite locus that can precisely discriminate LUAD samples and non-tumor samples (Velmurugan et al., 2017).”
BackgroundZheng, X., Zhou, C., Cheng, H., Hu, T., Liu, H.-S., Liu, X.-H., Wu, X., Wang, F.-W., Chen, Y., Wang, J., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-4849 · Cited by 1 · cited 3× · see citing works
“ATM AlDubayan et al., 2018 NRAS Meriggi et al., 2014 MTOR Wang and Zhang, 2014 SOX9 Prévostel and Blache, 2017 ADAMTSL3 ELMO1 Zheng et al., 2017 AMER1 KMT2B FBN2 KMT2A”
BackgroundInfluentialLoh, X. Y., Ding, L., & Koeffler, H. P. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-4494
Flagged first, then by citations
Cited by
Sorted by citations
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429 · see citing works
“For example, deepDriver 46 trained similarity networks and a convolutional neural network (CNN) on mutation data simultaneously to predict driver genes with better performance than the competing approaches when applied in breast cancer and colorectal cancer.”
Breast cancer detection using artificial intelligence techniques: A systematic literature review
Nassif, A. B., Talib, M. W. A., Nasir, Q., Afadar, Y., & Elgendy, O. (2022) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2022.102276 · Cited by 339 · see citing works
“[84] NCI Genomic Data Commons (GDC) Public Paid Https://gdc.”
BackgroundConvolutional neural network models for cancer type prediction based on gene expression
Mostavi, M., Chiu, Y., Huang, Y., & Chen, Y. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0677-2 · Cited by 266 · see citing works
Deep Learning Based Methods for Breast Cancer Diagnosis: A Systematic Review and Future Direction
Nasser, M., & Yusof, U. K. (2023) · Diagnostics · doi:10.3390/diagnostics13010161 · Cited by 227 · see citing works
“Additionally, for the purpose of studying and researching cancer, NCI Genomic Data Commons (GDC) [120] offers scholars a vast collection of gene-related data.”
BackgroundComputational network biology: Data, models, and applications
Liu, C., Ma, Y.-F., Zhao, J., Nussinov, R., Zhang, Y.-C., Cheng, F., & Zhang, Z.-K. (2020) · Physics Reports · doi:10.1016/j.physrep.2019.12.004 · Cited by 201 · see citing works
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
Lotter, W., Hassett, M. J., Schultz, N., Kehl, K. L., Van Allen, E. M., & Cerami, E. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1199 · Cited by 196 · see citing works
Incorporating Machine Learning into Established Bioinformatics Frameworks
Auslander, N., Gussow, A. B., & Koonin, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062903 · Cited by 143 · see citing works
“…genes, by incorporation of ML with statistical scoring of genomic sequencing [159], pathway-level mutations [160], mutation and gene interaction data [161], and by application of deep convolutional neural networks and random forest for analysis of mutations and gene similarity networks [162,163].”
MethodPeng, J., Li, J., & Shang, X. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03677-1 · Cited by 133 · see citing works
Cancer driver mutations: predictions and reality
Ostroverkhova, D. S., Przytycka, T. M., & Panchenko, A. R. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.03.007 · Cited by 131 · see citing works
Improving cancer driver gene identification using multi-task learning on graph convolutional network
Peng, W., Tang, Q., Dai, W., & Chen, T. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab432 · Cited by 130 · see citing works
A novel network control model for identifying personalized driver genes in cancer
Guo, W.-F., Zhang, S., Zeng, T., Li, Y., Gao, J., & Chen, L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007520 · Cited by 81 · see citing works
“On the other hand, the machine learning-based methods can be developed for any specific tasks depending on the available training data designed as pathogenic or neutral, but they have a few applications due to the probable incompleteness of their referred databases [6, 7].”
BackgroundKeeling, L. J., Winckler, C., Hintze, S., & Forkman, B. (2021) · Frontiers in Animal Science · doi:10.3389/fanim.2021.753080 · Cited by 83 · see citing works
Molecular Pathology of Lung CancerPreprint
Saller, J. J., & Boyle, T. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037812 · Cited by 79 · see citing works
Agajanian, S., Odeyemi, O., & Verkhivker, G. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00044 · Cited by 57 · see citing works
“A deep learning-based method (deepDriver) predicts driver genes by CNN trained with mutation-based feature matrix constructed using similarity networks (Luo et al., 2019).”
MethodNetwork control principles for identifying personalized driver genes in cancer
Guo, W.-F., Zhang, S.-W., Zeng, T., Akutsu, T., & Chen, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz089 · Cited by 44 · see citing works
Park, Y., Heider, D., & Hauschild, A.-C. (2021) · Cancers · doi:10.3390/cancers13133148 · Cited by 41 · see citing works
“It employed this convolution layer in a DNN by aggregating mutation information of the k-nearest neighboring genes [11].”
MethodFawaz, A., Ferraresi, A., & Isidoro, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111590 · Cited by 43 · see citing works
“Furthermore, the use of DNN models for large-scale data analysis enhanced the accuracy of computational models for the prediction of the muta-J tional landscape, molecular subtyping and drug repurposing [55–58].”
MethodMachine learning methods for prediction of cancer driver genes: a survey paper
de Andrades, R. S., & Recamonde‐Mendoza, M. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac062 · Cited by 40 · see citing works
“We also found four papers based on deep learning [36, 43, 48, 50] and three papers [25, 40, 51] adopting unsupervised learning techniques.”
BackgroundMethodInfluentialParrish, R. L., Gibson, G. C., Epstein, M. P., & Yang, J. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100068 · Cited by 34 · see citing works
“2 region, a mutation found to be associated with shorter overall survival,(66) and was predicted to be a driver of lung adenocarcinoma (MIM: 211980).(65) The test region of FRG1EP overlaps with the test region of pseudogene ANKRD20A21P, another TWAS risk gene identified by TIGAR, which has been implicated as a potenti…”
BackgroundPeng, L., Bai, Z., Liu, L., Yang, L., Liu, X., Chen, M., & Chen, X. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3476120 · Cited by 31 · see citing works
Ahmad, R. M., Ali, B. R., Al-Jasmi, F. A., Sinnott, R., Dhaheri, N. A., & Mohamad, M. S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad479 · Cited by 29 · see citing works
“DeepDriver [106] is an ML–based tool based on deep neural networks that performs convolution of variant-based features of genes and their neighbors in similarity networks.”
Nourbakhsh, M., Degn, K., Saksager, A. B., Tiberti, M., & Papaleo, E. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad519 · Cited by 30 · see citing works
“Examples include FI-Net [63], DeepDriver [64] and Deep-Cues [65].”
BackgroundMethodMulti-Network Graph Contrastive Learning for Cancer Driver Gene Identification
Peng, W., Zhou, Z., Dai, W., Yu, N., & Wang, J. (2024) · IEEE Transactions on Network Science and Engineering · doi:10.1109/tnse.2024.3373652 · Cited by 29 · see citing works
“DeepDriver [20] extracts 12 features from gene DNA sequences that are closely related to cancer development and then splices the features of each gene with the features of its K nearest neighboring nodes in the co-expression network to form a feature matrix of each gene, and then input the gene…”
BackgroundRevolutionizing Genomics: Exploring the Potential of Next-Generation Sequencing
Abdi, G., Tarighat, M. A., Jain, M., Tendulkar, R., Tendulkar, M., & Barwant, M. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-8401-5_1 · Cited by 28 · see citing works
DGMP: Identifying Cancer Driver Genes by Jointing DGCN and MLP from Multi-Omics Genomic Data
Zhang, S., Xu, J., & Zhang, T. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.11.004 · Cited by 28 · see citing works
“For example, deepDriver [26] predicted cancer driver genes with a convolutional neural network (CNN) model that was trained with the gene mutation features and their neighbors in the similarity networks.”
MethodNetwork Learning for Biomarker Discovery
Ding, Y., Fu, M., Luo, P., & Wu, F. (2023) · International Journal of Network Dynamics and Intelligence · doi:10.53941/ijndi0201004 · Cited by 28 · see citing works
Huang, X., Huang, K., Johnson, T. S., Radovich, M., Zhang, J., Ma, J., & Wang, Y. (2021) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqab097 · Cited by 27 · see citing works
“To address this problem, there has been great interest recently to apply deep learning to model the complexity of cancer mutations on various cancer types (10–13).”
BackgroundFatima, N., & Rueda, L. G. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa500 · Cited by 24 · see citing works
Identifying Disease-Gene Associations With Graph-Regularized Manifold Learning
Luo, P., Xiao, Q., Wei, P.-J., Liao, B., & Wu, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00270 · Cited by 22 · see citing works
“The typical machine learning-based methods extract gene-related features and train models that can discriminate disease genes and passenger genes (Mordelet and Vert, 2011; Yang et al., 2012; Singh-Blom et al., 2013; Luo et al., 2019a,b).”
MethodMachine learning approaches for predicting biomolecule–disease associations
Ding, Y., Lei, X., Liao, B., & Wu, F. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab002 · Cited by 22 · see citing works
Prediction of driver variants in the cancer genome via machine learning methodologies
Rogers, M. F., Gaunt, T. R., & Campbell, C. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa250 · Cited by 21 · see citing works
“DeepDriver [46], for example, based on use of a convolutional neural network.”
MethodPeng, W., Wu, R., Dai, W., & Yu, N. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05140-3 · Cited by 20 · see citing works
“DeepDriver [13] concatenates the features of the gene and its k nearest co-expression neighbours to generate a feature matrix for every gene.”
Background(2025) · doi:10.1038/s41467-025-58439-5 · Cited by 21 · see citing works
“DeepDriver [34] used gene mutation types as features, constructed a K-nearest neighbor graph based on the Pearson correlation coefficient, and trained a convolutional neural network to iden-84 tify cancer risk genes.”
Hosen, M. F., Mahmud, S., Ahmed, K., Chen, W., Moni, M. A., Deng, H., Shoombuatong, W., & Hasan, M. M. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105433 · Cited by 16 · see citing works
Morabito, F., Adornetto, C., Monti, P., Amaro, A. A., Reggiani, F., Colombo, M., Aldana, Y. R., Tripepi, G. L., D’Arrigo, G., Vener, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1198992 · Cited by 17 · see citing works
Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network
Liu, C., Dai, Y., Yu, K., & Zhang, Z. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3063532 · Cited by 17 · see citing works
MiRNA–gene network embedding for predicting cancer driver genes
Peng, W., Wu, R., Dai, W., Ning, Y., Fu, X., Liu, L., & Liu, L. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac059 · Cited by 16 · see citing works
Jubran, J., Slutsky, R., Rozenblum, N., Rokach, L., Ben‐David, U., & Yeger‐Lotem, E. (2024) · Genome biology · doi:10.1186/s13059-024-03225-7 · Cited by 14 · see citing works
“In the context of cancer, supervised ML methods were applied to predict cancer driver genes [17, 18], to distinguish between cancer types [19, 20], and to predict gene dependency in tumors [21].”
MethodDeep Learning Techniques in Cancer Prediction Using Genomic Profiles
Bhonde, S. B., & Prasad, J. R. (2021) · IEEE International Conference for Convergence in Technology (I2CT) · doi:10.1109/i2ct51068.2021.9417985 · Cited by 15 · see citing works
Chu, X., Guan, B., Dai, L.-Y., Liu, J., Li, F., & Shang, J. (2023) · BMC Genomics · doi:10.1186/s12864-023-09515-x · Cited by 14 · see citing works
“The method allows the convolutional neural network to learn information within mutation data and similarity networks simultaneously, which enhances the prediction of driver genes [18].”
MethodWei, T., Fa, B., Luo, C., Johnston, L. J., Zhang, Y., & Yu, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.613033 · Cited by 13 · see citing works
“DeepDriver predicts cancer driver genes based on mutation-based features and gene similarity networks using deep convolutional neural networks (Luo et al., 2019).”
BackgroundHassan, A., Alkhalifah, T., Alturise, F., & Khan, Y. D. (2022) · Diagnostics · doi:10.3390/diagnostics12123036 · Cited by 12 · see citing works
Meng, P., Wang, G., Guo, H., & Jiang, T. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106810 · Cited by 11 · see citing works
Parvandeh, S., Donehower, L. A., Katsonis, P., Hsu, T., Asmussen, J. K., Lee, K. D., & Lichtarge, O. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac215 · Cited by 11 · see citing works
Wadapurkar, R. M., Bapat, S., Mahajan, R. A., & Vyas, R. (2023) · Data Technologies and Applications · doi:10.1108/dta-03-2022-0096 · Cited by 11 · see citing works
XMR: an explainable multimodal neural network for drug response prediction
Wang, Z., Zhou, Y., Zhang, Y., Yu, M., & Wang, Y. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1164482 · Cited by 11 · see citing works
“DL has been successful in a variety of drug discovery tasks and may outperform traditional machine learning approaches in drug response prediction (Yuan et al., 2016; Luo et al., 2019; Sun et al., 2019; Jiao et al., 2020) despite being underexplored until recently.”
BackgroundYang, J., Fu, H., Xue, F., Li, M., Wu, Y., Yu, Z., Luo, H., Gong, J., Niu, X., & Zhang, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae418 · Cited by 10 · see citing works
“Methods like MuSiC [7],MutSigCV [8],deepDriver [9],and OncodriveCLUST [10] predict cancer genes through mutation analysis.”
MethodIdentifying cancer driver genes in individual tumours
Gillman, R., Field, M. A., Schmitz, U., Karamatic, R., & Hebbard, L. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.019 · Cited by 9 · see citing works
“Indeed, this approach has shown promise for large cohort data with several tools being recently developed (DriverML [68], DeepDriver [69], CHASM [30], and AI-Driver [70]).”
MethodCancerGATE: Prediction of cancer-driver genes using graph attention autoencoders
Jung, S., Wang, S., & Lee, D. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108568 · Cited by 9 · see citing works
Trans-Driver: A Deep Learning Approach for Cancer Driver Gene Discovery With Multi-Omics Data
Yang, H., Yang, Z., Zhang, L., Yang, Y., Zhou, D., Li, D., Zhang, J., & Wang, Z. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3612010 · Cited by 9 · see citing works
Identification of cancer types from gene expressions using learning techniques
Bhonde, S. B., Wagh, S. K., & Prasad, J. R. (2022) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2022.2160243 · Cited by 9 · see citing works
“The last decade has witnessed abundant use of DL algorithms, which has the exciting potential to uncover complicated interactions buried in large-scale information including bioinformatics (Luo et al. 2019).”
BackgroundZhang, D., & Bin, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.607798 · Cited by 9 · see citing works
“DeepDriver employs deep learning to identify driver genes by estimating the functional impact of mutations (Luo et al., 2019 ).”
BackgroundGupta, P., Jindal, A., Ahuja, G., Jayadeva, & Sengupta, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102177 · Cited by 9 · see citing works
“Notably, AFF2 has recently been predicted to have driver roles (32).”
BackgroundZhang, S., Wang, Z., Li, Y., & Guo, W.-F. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04802-y · Cited by 9 · see citing works
Gangurde, R. A., Jagota, V., Khan, M. S., Sakthi, V. S., Boppana, U. M., Osei, B., & Kishore, K. H. (2023) · BioMed Research International · doi:10.1155/2023/6970256 · Cited by 9 · see citing works
“To effectively characterize tumours, machine learning and statistical techniques such as decision trees, k-nearest neighbour, support vector machines, and neural network techniques are being used [48].”
MethodRetractedMutBLESS: A tool to identify disease-prone sites in cancer using deep learning
Pandey, M., & Gromiha, M. M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166721 · Cited by 8 · see citing works
Ma, X., Li, Z., Du, Z., Xu, Y., Chen, Y., Zhuo, L., Fu, X., & Liu, R. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108484 · Cited by 7 · see citing works
Taheri, G., & Habibi, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108234 · Cited by 8 · see citing works
Zimmerman, L., Zelichov, O., Aizenman, A., Barbash, Z. S., Vidne, M., & Tarcic, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-61173-1 · Cited by 7 · see citing works
“In cancer genetics, deepDriver 26 is a notable example of the application of DCNNs for the task of cancer driver genes prediction.”
BackgroundWeighted minimum feedback vertex sets and implementation in human cancer genes detection
Li, R., Lin, C., Guo, W.-F., & Akutsu, T. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04062-2 · Cited by 7 · see citing works
IDriveGenes: Cancer Driver Genes Prediction Using Machine Learning
Ali, Y., Sardaraz, M., Tahir, M., Elmannai, H., Hamdi, M., & Ksibi, A. (2023) · IEEE Access · doi:10.1109/access.2023.3259907 · Cited by 6 · see citing works
“Research paper [29] presents deepDriver framework that predicts cancer driver genes using a Convolutional Neural Network (CNN) based on somatic mutations.”
BackgroundZhang, B., & Fan, T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.951939 · Cited by 6 · see citing works
“The framework by Mallik et al. integrated linear regression, differential expression, and deep learning and facilitated the robust interpretation of DNA methylation signatures and gene expression data for cervical cancer Mallik et al., (2020). Poirion et al., using multi-omics data, established a deep learning ensembl…”
MethodYang, H., Ding, Y., Tang, J., & Guo, F. (2021) · BMC Genomics · doi:10.1186/s12864-021-07864-z · Cited by 5 · see citing works
Zhang, L., Deng, T., Liufu, Z., Liu, X., Chen, B., Hu, Z., Liu, C., Tracy, M. E., Lu, X., Wen, H., et al. (2024) · eLife · doi:10.7554/elife.99340 · Cited by 5 · see citing works
Esmaeilzadeh, A. A., Kashian, M., Salman, H. M., Alsaffar, M. F., Jaber, M. M., Soltani, S., İlhan, A., & Bahrami, A. (2022) · Biology · doi:10.3390/biology11121851 · Cited by 3 · see citing works
RetractedChen, Y., Li, G., Liu, T., Zhou, R., Mao, Y., Wu, J., Liu, J., Hu, H., Wu, K., & Zhu, Q. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3574337 · Cited by 3 · see citing works
“Luo et al. proposed deepDriver, a convolutional neural network (CNN)- based method for cancer driver gene prediction, which integrates biological similarity networks with mutational functional impact features [10].”
Discovery of pan-cancer related genes via integrative network analysis
Zhu, Y., Zhang, H., Yang, Y., Zhang, C., Ou-Yang, L., Bai, L., Deng, M., Yi, M., Liu, S., & Wang, C. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac012 · Cited by 3 · see citing works
GATOmics: A Novel Multi-Omics Graph Attention Network Model for Cancer Driver Gene Detection
Kong, G., Wang, J., & Wang, J. (2025) · IEEE International Conference on Acoustics Speech and Signal Processing · doi:10.1109/icassp49660.2025.10889716 · Cited by 3 · see citing works
“Methods like RLAG [18] and DeepDriver [19] have employed network representation learning to improve predictions, while Graph Convolutional Networks (GCN) [20], such as EMOGI [21] and MTGCN [22], have shown promise by integrating omics data with PPI networks.”
Predicting of Autism Spectrum Disorder using Gene Ontology
Ismail, E., Gad, W. K., & Hashem, M. (2021) · International Conference on Intelligent Computing and Information Systems (ICICIS) · doi:10.1109/icicis52592.2021.9694254 · Cited by 3 · see citing works
Xi, J., Deng, Z., Liu, Y., Wang, Q., & Shi, W. (2023) · PeerJ · doi:10.7717/peerj.14843 · Cited by 3 · see citing works
“Since the most relevant basis of cancer drivers is DNA aberrations in cancer samples, the existing computational driver detection approaches mainly focus on DNA sequencing data, and utilize the information of aberrations like single nucleotide variations [9, 10, 11], copy number alternations [12, 13], and structural v…”
InfluentialAgajanian, S. (2021) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000220 · Cited by 3 · see citing works
A Novel Machine Learning Model for Identifying Patient-Specific Cancer Driver Genes
Jung, H., Choi, J., Park, J., & Ahn, J. (2022) · IEEE Access · doi:10.1109/access.2022.3176376 · Cited by 2 · see citing works
“The second group is based on machine learning models, which learn genetic or transcriptomic patterns of known driver mutations or genes [3]–[6].”
BackgroundHGTDG: An Interpretable Heterogeneous Graph Transformer Framework for Cancer Driver Gene Prediction
Xiong, S., Wang, Z., Zhang, J., Zhu, G., Zhang, Y., & Zou, Q. (2023) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm58861.2023.10385343 · Cited by 2 · see citing works
“Many efforts have been made to predict cancer driver genes through computational approaches, most based on machine learning algorithms [4]–[6].”
BackgroundLaganà, A. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-55248-9_8 · Cited by 2 · see citing works
Capsule neural network and its applications in drug discovery
Wang, Y., Wang, B., Zou, J., Wu, A., Liu, Y., Wan, Y., Luo, J., & Wu, J. (2025) · iScience · doi:10.1016/j.isci.2025.112217 · Cited by 2 · see citing works
“78 Understanding the three-dimensional structure of targets is crucial for designing drugs to either inhibit or activate their functions.”
Mining the Human Metabolome for Precision Oncology Research
Edoho, M. E., Ekpenyong, M. E., Momodu, A. B., & Joseph, G. (2020) · International Conference on Medical and Health Informatics (ICMHI) · doi:10.1145/3418094.3418123 · Cited by 2 · see citing works
“The present development has resulted in an increased driver genes validation using machine learning algorithms [7, 8, 11-19], and demonstrates the superiority of machine learning models, given limited knowledge of driver-disease associations.”
MethodYan, J., Hu, Z., Li, Z., Sun, S., & Guo, W.-F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891676 · Cited by 2 · see citing works
“(1) In gene mutation frequency-based methods, the mutation frequency of driver genes is usually assumed to be signi fi cantly higher than that of other genes (13, 47 – 51).”
BackgroundPark, J., & Jo, K. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3643887 · Cited by 1 · see citing works
“The comparative analysis results for individual cancers are shown in Table VI. DiffMut [6], GUST [8]), deepDriver [10], MODIG [13] are selected as the representatives of each category: statistical model, machine learning, deep learning with network information and graph neural network.”
Alotaibi, E. M., Alkhnbashi, O. S., & Tran, V. D. (2026) · Scientific Reports · doi:10.1038/s41598-026-36127-8 · Cited by 1 · see citing works
“To address these limitations, deep learning and machine learning techniques have been applied to learn complex mutational patterns from multi-omics data, including single-nucleotide variants (SNVs), copy number variations (CNVs), gene expression, and DNA methylation 11–13 .”
Yi, X., Han, Z., Lu, D., Xu, H., Zheng, X. S., Tang, Y., Li, J., Li, X., Liao, D., Li, H., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.02.003 · Cited by 2 · see citing works
Yu, L., & Ren, S. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0324 · Cited by 1 · see citing works
GASN: gamma distribution test for driver genes identification based on similarity networks
Jiang, D., Wei, R., He, Z., Lin, S., Liu, C., & Lin, Y. (2023) · Connection Science · doi:10.1080/09540091.2023.2167937 · Cited by 1 · see citing works
“In the gene similarity network, genes and their adjacent genes also have similar properties (de Vries, 2020; Luo et al., 2019).”
BackgroundRuhela, V., Jena, L., Kaur, G., Gupta, R., & Gupta, A. (2023) · PubMed Central · Cited by 1 · see citing works
Advances in computational methods for identifying cancer driver genes
Wang, Y., Zhou, B., Ru, J., Meng, X., Wang, Y., & Liu, W. (2023) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023958 · Cited by 1 · see citing works
Xiong, S., Zhang, J., Luo, H., Zhang, Y., & Xiao, Q. (2024) · Methods · doi:10.1016/j.ymeth.2024.09.018 · Cited by 1 · see citing works
Saha, P., & Cerono, G. (2023) · Journal of Emerging Investigators · doi:10.59720/23-025 · Cited by 1 · see citing works
Zhang, L., Deng, T., Liufu, Z., Liu, X., Chen, B., Hu, Z., Liu, C., Tracy, M. E., Lu, X., Wen, H., et al. (2024) · eLife · doi:10.7554/elife.99340.2 · Cited by 1 · see citing works
Lischer, C., & Vera, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11605-8
Odeyemi, O. (2020) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000155
“DeepDriver- A deep learning-based method predicts driver mutations by CNN trained with a mutation-based feature matrix constructed using similarity metrics (Luo et al., 2019).”
MethodIncorporating Machine Learning Into Bioinformatics Frameworks
Auslander, N., Gussow, A. B., & Koonin, E. V. (2021)
IMRDriver: coding and non-coding cancer driver genes identification based on network propagation
Wang, S., Huang, X., Chan, K. H. K., & Gao, L. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995249
“The mutation-based strategy, such as ActiveDriver[6], CoMEt[7], DriverML[8], MutSigCV[9], OncodriveCLUST[10], e-Driver[11], Dendrix[12], iPAC[13], MSEA[14], deepDriver[15], EPIMUTESTR[16] aims to identify CDGs by analyzing gene mutations and their related features.”
MethodBRDriver: Breast Cancer Driver Gene PredictorPreprint
Perera, R., & Perera, R. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.09.523362
“Many computational tools and methods were developed using genetic data to identify the driver genes from the passenger genes [6].”
MethodAdoption of Artificial Intelligence in Human and Clinical Genomics
Jain, D. K., Zhang, L., Zhang, G., & Shukla, P. K. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-2184-7
Tumor genomics in radiotherapy
Cui, S., Speers, C. W., & Naqa, I. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822000-9.00007-0
Deep learning mediated identification of the origins of cancer of unknown primary
Divate, M. D. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.246033
Zhang, S., Wang, Z., Li, Y., & Guo, W.-F. (2022) · Figshare · doi:10.6084/m9.figshare.20499900
Zhang, S., Wang, Z., Li, Y., & Guo, W.-F. (2022) · Figshare · doi:10.6084/m9.figshare.20499894
- Authors
- Luo, P., Ding, Y., Lei, X., & Wu, F.-X.
- Affiliations
- University of Saskatchewan (CA)
- Shaanxi Normal University (CN)
- Hainan Normal University (CN)
- Corresponding author
- Wu, Fang-Xiang
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2019-01-29
- Volume
- 10
- Pages
- 13-13
- ISSN
- 1664-8021 (ISSN-L)
- PMC
- PMC6361806
- OpenAlex
- W2913030342
- Cited by
- 107
- References
- 54
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 19 · 2023: 30 · 2022: 17 · 2021: 17 · 2020: 9 · 2019: 5
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- China Scholarship Council
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- cancer driver genes, somatic mutations, deep convolutional neural networks, similarity networks, multi-omics integration, breast cancer, colorectal cancer, oncogenic mutations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
